Artiva Biotherapeutics In... (ARTV)
NASDAQ: ARTV
· Real-Time Price · USD
2.78
-0.23 (-7.64%)
At close: Oct 16, 2025, 3:59 PM
-7.64% (1D)
| Bid | 2.82 |
| Market Cap | 67.9M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -68.25M |
| EPS (ttm) | -6.15 |
| PE Ratio (ttm) | -0.45 |
| Forward PE | -0.84 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.06 |
| Volume | 39,328 |
| Avg. Volume (20D) | 105,723 |
| Open | 2.87 |
| Previous Close | 3.01 |
| Day's Range | 2.75 - 2.87 |
| 52-Week Range | 1.47 - 15.49 |
| Beta | 5.29 |
| Ex-Dividend Date | n/a |
About ARTV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARTV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARTV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 hours ago
Artiva Biotherapeutics shares are trading higher a...
Unlock content with
Pro Subscription
11 months ago
-10.48%
Artiva Biotherapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results.
